These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10933131)

  • 1. Intravenous formulations of the enantiomers of thalidomide: pharmacokinetic and initial pharmacodynamic characterization in man.
    Eriksson T; Björkman S; Roth B; Höglund P
    J Pharm Pharmacol; 2000 Jul; 52(7):807-17. PubMed ID: 10933131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of thalidomide.
    Eriksson T; Björkman S; Höglund P
    Eur J Clin Pharmacol; 2001 Aug; 57(5):365-76. PubMed ID: 11599654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide.
    Eriksson T; Björkman S; Roth B; Fyge A; Höglund P
    Chirality; 1995; 7(1):44-52. PubMed ID: 7702998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind study of the sedative effects of the thalidomide enantiomers in humans.
    Höglund P; Eriksson T; Björkman S
    J Pharmacokinet Biopharm; 1998 Aug; 26(4):363-83. PubMed ID: 10214558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The enantiomers of the teratogenic thalidomide analogue EM 12: 1. Chiral inversion and plasma pharmacokinetics in the marmoset monkey.
    Schmahl HJ; Nau H; Neubert D
    Arch Toxicol; 1988; 62(2-3):200-4. PubMed ID: 3143339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantiomers of thalidomide: blood distribution and the influence of serum albumin on chiral inversion and hydrolysis.
    Eriksson T; Björkman S; Roth B; Fyge A; Höglund P
    Chirality; 1998; 10(3):223-8. PubMed ID: 9499573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in analytical determination of thalidomide and its metabolites.
    Bosch ME; Sánchez AJ; Rojas FS; Ojeda CB
    J Pharm Biomed Anal; 2008 Jan; 46(1):9-17. PubMed ID: 18023317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of thalidomide.
    Teo SK; Colburn WA; Tracewell WG; Kook KA; Stirling DI; Jaworsky MS; Scheffler MA; Thomas SD; Laskin OL
    Clin Pharmacokinet; 2004; 43(5):311-27. PubMed ID: 15080764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new method for determination of both thalidomide enantiomers using HPLC systems.
    Sembongi K; Tanaka M; Sakurada K; Kobayashi M; Itagaki S; Hirano T; Iseki K
    Biol Pharm Bull; 2008 Mar; 31(3):497-500. PubMed ID: 18310917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide enantiomers: determination in biological samples by HPLC and vancomycin-CSP.
    Murphy-Poulton SF; Boyle F; Gu XQ; Mather LE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):48-56. PubMed ID: 16321578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of antiinflammatory and antitumorigenic properties of stabilized enantiomers of thalidomide analogs.
    Jacques V; Czarnik AW; Judge TM; Van der Ploeg LH; DeWitt SH
    Proc Natl Acad Sci U S A; 2015 Mar; 112(12):E1471-9. PubMed ID: 25775521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enantioselective pharmacokinetics of the enantiomers of clevidipine following intravenous infusion of the racemate in essential hypertensive patients.
    Ericsson H; Schwieler J; Lindmark BO; Löfdahl P; Thulin T; Regårdh CG
    Chirality; 2001; 13(3):130-4. PubMed ID: 11270321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling and simulation to probe the pharmacokinetic disposition of pomalidomide R- and S-enantiomers.
    Li Y; Zhou S; Hoffmann M; Kumar G; Palmisano M
    J Pharmacol Exp Ther; 2014 Aug; 350(2):265-72. PubMed ID: 24833703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enantiomers of the teratogenic thalidomide analogue EM 12. 2. Chemical stability, stereoselectivity of metabolism and renal excretion in the marmoset monkey.
    Schmahl HJ; Heger W; Nau H
    Toxicol Lett; 1989 Jan; 45(1):23-33. PubMed ID: 2492686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantioselectivity of thalidomide serum and tissue concentrations in a rat glioma model and effects of combination treatment with cisplatin and BCNU.
    Murphy S; Boyle FM; Davey RA; Gu XQ; Mather LE
    J Pharm Pharmacol; 2007 Jan; 59(1):105-14. PubMed ID: 17227627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics.
    Scheffler MR; Colburn W; Kook KA; Thomas SD
    Clin Pharmacol Ther; 1999 May; 65(5):483-90. PubMed ID: 10340913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy Subjects.
    Lorier M; Magallanes L; Ibarra M; Guevara N; Vázquez M; Fagiolino P
    Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):787-793. PubMed ID: 26590950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and synovial fluid concentrations of flurbiprofen enantiomers in horses: chiral inversion.
    Soraci AL; Tapia O; Garcia J
    J Vet Pharmacol Ther; 2005 Feb; 28(1):65-70. PubMed ID: 15720517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the Thalidomide Chirality in Biological Processes by the Self-disproportionation of Enantiomers.
    Tokunaga E; Yamamoto T; Ito E; Shibata N
    Sci Rep; 2018 Nov; 8(1):17131. PubMed ID: 30459439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of thiopental enantiomers during and following prolonged high-dose therapy.
    Cordato DJ; Mather LE; Gross AS; Herkes GK
    Anesthesiology; 1999 Dec; 91(6):1693-702. PubMed ID: 10598612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.